TapImmune, Marker Therapeutics merge

TapImmune (NASDAQ:TPIV) will merge with Marker Therapeutics Inc. (New Brighton, Minn.) to create a new

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE